
Curcumin-no longer merely a culinary spice or folk medicine, but an ingredient with a track record of research-backed health benefits-is set for another big year in 2018.

The sports drinks market is continuing to diversify, with consumers driving demand for healthier sports drinks products. This demand for healthy drinks-coupled with growing niches that have very specific functional needs-is likely to open up new opportunities for brands that fine-tune their formulations and marketing in response.

Curcumin-no longer merely a culinary spice or folk medicine, but an ingredient with a track record of research-backed health benefits-is set for another big year in 2018.

GOED issued a statement to its members affirming several points, including that the meta-analysis, which showed that omega-3 fatty acid supplementation had no significant associations with CHD death, nonfatal myocardial infarction, any coronary heart disease events, or major vascular events, adds little to the current body of evidence surrounding omega-3s and cardiovascular risk factors.

The company says that its first food-grade potassium chloride facility will help manufacturers lower products' sodium content by up to 50%.

Researchers noted that while surgical and trans catheter aortic valve replacements can treat severe symptomatic calcific aortic valve stenosis cases, not all patients are good candidates for the procedures.

Both formulas deliver 400 mg of turmeric extract standardized to 95% curcuminoids per serving, concentrating the dose of curcumin that consumers receive.

The report has been posted to the Codex Alimentarius Commission website.

The company said that consumers’ failure to correctly identify “bad” cholesterol highlights the importance of consumer education.

A look at why CoQ10 has remained a go-to heart health ingredient for decades.

In its response, the ITC stated that “Amarin’s complaint does not allege an unfair method of competition or an unfair act cognizable under 19 U.S.C. § 1337(a)(1)(A), as required by the statute and the Commission’s rules.”

Recent studies indicate magnesium’s growing importance for mental health, arterial flexibility, and metabolic function.

Recent studies show whey protein’s benefits in cases of sarcopenia, high blood pressure, and more.

The study is the latest product of a long-term collaboration that Rimfrost established with the University of Bergen for the purpose of learning more about the biological effects and mechanisms of action of proteins and lipids derived from Antarctic krill.

An expanding body of research points to the significant benefits of tocotrienols.

Manufacturers have laid the groundwork to succeed in the fast-growing high-flavanol cocoa category, but there is work still to be done to show consumers that high-flavanol products are more than just desserts.

Do calcium supplements really increase cardiovascular risk? Here’s what the latest research says.

NattoPharma (Oslo, Norway) unveiled its latest vitamin K2 innovation yet at this year’s SupplySide West trade show: the industry’s first and only full-spectrum vitamin K2 ingredient that comprehensively provides menaquinones (MK) 6, 7, 8, and 9, all vital to heart health.

Will brands and formulators have to do better than simply offering higher concentrates in order to keep consumer interested in omega-3s supplements?

In two filings submitted to the International Trade Commission, CRN argued that Amarin was “financially motivated” to expand its near monopoly over a subset of omega-3 products; if successful, CRN says, Amarin’s complaint would make it much more difficult and costly for consumers to access those products.

The prospective study, which included 135,335 participants, found that excessive consumption of carbohydrates is a contributing factor to total mortality.

Amarin’s ITC complaint alleges that synthetically produced omega-3 products that are predominantly composed of EPA in either ethyl ester or re-esterified form are not considered “dietary ingredients” under Section 201(ff)(1) of the Federal Food Drug and Cosmetic Act, and thus, are not legal dietary supplements but unapproved new drugs.

The meta-analysis, comprising 14 randomized, controlled trials featuring 71,899 subjects, found that omega-3s EPA and DHA supplementation may reduce the risk of cardiac death by 8%, and that benefits may be even greater for subjects with elevated triglycerides or LDL cholesterol.

New studies on garlic focus on coronary plaque reduction, immune health, liver function, and weight management.

In the study, performed in subjects with type 2 diabetes, Sabinsa’s Curcumin C3 Complex together with its BioPerine bioavailability booster demonstrated, for the first time, a reduction in lipoprotein(a), a “protective armor” of LDL cholesterol.

The claim confirms soybean oil’s ability to reduce the risk of coronary heart disease.

Research shows that even moderate cocoa consumption may benefit heart, brain, and skin health.